CN Patent

CN117642153A — 易蚀片剂

Assigned to Eli Lilly and Co · Expires 2024-03-01 · 2y expired

What this patent protects

本发明涉及适合于口服施用的包含治疗性肽的易蚀片剂，并且另外，还涉及用于制备易蚀片剂的非制粒方法。

USPTO Abstract

本发明涉及适合于口服施用的包含治疗性肽的易蚀片剂，并且另外，还涉及用于制备易蚀片剂的非制粒方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN117642153A
Jurisdiction: CN
Classification: —
Expires: 2024-03-01
Drug substance claim: No
Drug product claim: No
Assignee: Eli Lilly and Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.